$The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.$

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.

Show other versions (1)

Manylion Llyfryddiaeth
Prif Awduron:	van Staal, T, Eastell, R, Barton, I, Rizzoli, R, Javaid, M, Cooper, C
Fformat:	Conference item
Cyhoeddwyd:	2003

Eitemau Tebyg

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
gan: van Staa, T, et al.
Cyhoeddwyd: (2003)

PREDICTORS FOR VERTEBRAL FRACTURES AND FRACTURE THRESHOLD IN PATIENTS USING ORAL GLUCOCORTICOIDS
gan: van Staa, T, et al.
Cyhoeddwyd: (2003)

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
gan: Van Staa, T, et al.
Cyhoeddwyd: (2003)

A meta-analysis of reference markers of bone turnover for prediction of fracture
gan: Johansson, H, et al.
Cyhoeddwyd: (2014)

A meta-analysis of reference markers of bone turnover for prediction of fracture.
gan: Johansson, H, et al.
Cyhoeddwyd: (2014)

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
gan: Vasikaran, S, et al.
Cyhoeddwyd: (2011)

Markers of bone turnover and disease status in prostate cancer
gan: Hannon, R, et al.
Cyhoeddwyd: (2003)

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
gan: Vasikaran, S, et al.
Cyhoeddwyd: (2011)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
gan: Watts, N, et al.
Cyhoeddwyd: (2004)

CUMULATIVE RISKS OF FRACTURE IN PATIENTS USING ORAL GLUCOCORTICOIDS
gan: Van Staa, T, et al.
Cyhoeddwyd: (2004)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
gan: Watts, N, et al.
Cyhoeddwyd: (2004)

VERTEBRAL FRACTURE RISK REDUCTION IS INDEPENDENT OF THE MAGNITUDE OF BMD CHANGE
gan: Adachi, J, et al.
Cyhoeddwyd: (2004)

Vertebral fractures predict subsequent fractures.
gan: Melton, L, et al.
Cyhoeddwyd: (1999)

Fracture risk with intermittent high-dose oral glucocorticoid therapy.
gan: De Vries, F, et al.
Cyhoeddwyd: (2007)

Bone turnover markers: Do they explain risk associated with previous fracture? The epos study
gan: Vergnaud, P, et al.
Cyhoeddwyd: (2000)

Bone turnover markers: Do they explain risk associated with previous fracture? The EPOS study
gan: Vergnaud, P, et al.
Cyhoeddwyd: (2000)

Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
gan: van Staa, T, et al.
Cyhoeddwyd: (2007)

Risk of incident fracture is associated with dose, duration and recency of oral glucocorticoid exposure
gan: Robinson, DE, et al.
Cyhoeddwyd: (2018)

Bone loss and inhaled glucocorticoids.
gan: van Staa, T, et al.
Cyhoeddwyd: (2002)

The associations between QCT-based vertebral bone measurements and prevalent vertebral fractures depend on the spinal locations of both bone measurement and fracture
gan: Demissie, S., et al.
Cyhoeddwyd: (2016)

Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: the Taiji study.
gan: Yoshimura, N, et al.
Cyhoeddwyd: (1999)

Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
gan: Blumsohn, A, et al.
Cyhoeddwyd: (2011)

The limitations of using simple definitions of glucocorticoid exposure on the prediction of fracture risk
gan: Robinson, D, et al.
Cyhoeddwyd: (2018)

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids.
gan: van Staa, T, et al.
Cyhoeddwyd: (2005)

Risk of new vertebral fracture in the year following a fracture.
gan: Lindsay, R, et al.
Cyhoeddwyd: (2001)

Bone remodelling does not decline after menopause in vertebral fracture osteoporosis.
gan: Wand, J, et al.
Cyhoeddwyd: (1992)

Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group.
gan: Black, D, et al.
Cyhoeddwyd: (1999)

CHARACTERISTICS OF PREVALENT VERTEBRAL DEFORMITY AND THE RISK OF INCIDENT VERTEBRAL FRACTURE
gan: Lunt, M, et al.
Cyhoeddwyd: (2002)

The relationship between bone density and incident vertebral fracture in men and women.
gan: O'Neill, T
Cyhoeddwyd: (2002)

The importance of vertebral fracture
gan: Reeve, J, et al.
Cyhoeddwyd: (2003)

Bisphosphonates prevent bone loss early after renal transplantation with concomitant fall in bone turnover markers
gan: Hofker, H, et al.
Cyhoeddwyd: (2007)

Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy.
gan: Varonos, S, et al.
Cyhoeddwyd: (1987)

The localisation of glucocorticoid receptors in human bone
gan: Abu, E, et al.
Cyhoeddwyd: (1997)

Health-related quality of life and radiographic vertebral fracture.
gan: Cockerill, W, et al.
Cyhoeddwyd: (2004)

Letter to the editor: re: Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women?
gan: Reeve, J
Cyhoeddwyd: (2016)

Low grip strength is associated with bone mineral density and vertebral fracture in women.
gan: Dixon, W, et al.
Cyhoeddwyd: (2005)

The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: a cohort study
gan: Robinson, D, et al.
Cyhoeddwyd: (2018)

QUALITY OF LIFE AND RADIOGRAPHIC VERTEBRAL FRACTURE
gan: O'Neill, T, et al.
Cyhoeddwyd: (2002)

Periarticular bone loss in arthritis: Role of synovial glucocorticoid generation
gan: Cooper, MS, et al.
Cyhoeddwyd: (2010)

VERTEBRAL FRACTURES: DEFINITION, CLINICAL IMPACT AND EPIDEMIOLOGICAL CONSIDERATIONS
gan: Cooper, C
Cyhoeddwyd: (2012)